📣 VC round data is live. Check it out!
- Public Comps
- TransMedics
TransMedics Valuation Multiples
Discover TransMedics' revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like Sinbon Electronics, Double Medical Technology, Insight Lifetech, Elekta and more.
TransMedics Overview
About TransMedics
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Founded
2018
HQ

Employees
898
Website
Financials (LTM)
EV
$3B
Valuation Multiples
Start free trialTransMedics Financials
TransMedics reported last 12-month revenue of $659M and EBITDA of $159M.
In the same LTM period, TransMedics generated $393M in gross profit, $159M in EBITDA, and $142M in net income.
Revenue (LTM)
TransMedics P&L
In the most recent fiscal year, TransMedics reported revenue of $605M and EBITDA of $163M.
TransMedics is profitable as of last fiscal year, with gross margin of 60%, EBITDA margin of 27%, and net margin of 31%.
Financial data powered by Morningstar, Inc.
TransMedics Stock Performance
TransMedics has current market cap of $2B, and enterprise value of $3B.
Market Cap Evolution
TransMedics' stock price is $68.45.
TransMedics share price increased by 1.9% in the last 30 days, and decreased by 48.9% in the last year.
TransMedics has an EPS (earnings per share) of $5.51.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3B | $2B | 1.4% | 1.9% | -31.1% | -48.9% | $5.51 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialTransMedics Valuation Multiples
TransMedics trades at 4.2x EV/Revenue multiple, and 17.4x EV/EBITDA.
EV / Revenue (LTM)
TransMedics Financial Valuation Multiples
As of June 3, 2026, TransMedics has market cap of $2B and EV of $3B.
TransMedics has a P/E ratio of 16.7x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified TransMedics Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


TransMedics Margins & Growth Rates
TransMedics grew revenue by 21% but EBITDA decreased by 5% in the last fiscal year.
In the most recent fiscal year, TransMedics reported gross margin of 60%, EBITDA margin of 27%, and net margin of 31%.
TransMedics Margins
TransMedics Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
TransMedics Operational KPIs
TransMedics' revenue per employee in the last FY averaged $0.7M, while opex per employee averaged $0.3M for the same period.
TransMedics' Rule of 40 is 42% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
TransMedics' Rule of X is 74% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
TransMedics Competitors
TransMedics competitors include Sinbon Electronics, Double Medical Technology, Insight Lifetech, Elekta, Tecan Group, GN Store Nord, Jeol, Jafron Biomedical, Axogen and LeMaitre Vascular.
Most TransMedics public comparables operate across Medical Devices, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 2.3x | 2.3x | 15.9x | 17.6x | |||
| 5.9x | 5.6x | 16.4x | 13.9x | |||
| 29.2x | - | 131.6x | - | |||
| 1.5x | 1.5x | 11.4x | 10.8x | |||
| 2.1x | 2.1x | 14.0x | 13.9x | |||
| 1.4x | 1.6x | 8.8x | 9.5x | |||
| 1.7x | 1.9x | 11.2x | 10.5x | |||
| 6.5x | 6.3x | 13.3x | 13.2x | |||
This data is available for Pro users. Sign up to see all TransMedics competitors and their valuation data. Start Free Trial | ||||||
TransMedics VC Funding History
Before going public, TransMedics raised $84M in total equity funding, across 4 rounds.
TransMedics Funding Rounds
Acquisitions by TransMedics
TransMedics has acquired 1 company to date.
Last acquisition by TransMedics was on August 1st 2023. TransMedics acquired Summit Aviation for $18M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by TransMedics
| Description | Summit Aviation is a Greenwich, Connecticut-based charter and aircraft management company that operates a fleet including Cessna Citations, Gulfstream jets, and single-engine pistons. The firm provides Part 135 charter services, FBO operations at Essex County Airport, and maintenance for business and leisure flights across the Northeast United States. |
| HQ Country | |
| HQ City | - |
| Deal Date | 1 Aug 2023 |
| Valuation | $18M |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all TransMedics acquisitions and their M&A valuation multiples. Start Free Trial | |
Investments by TransMedics
TransMedics has invested in 1 company to date.
Latest investment by TransMedics was on April 28th 2026. TransMedics invested in Padaviation in their Strategic investment round.
Latest Investments by TransMedics
| Description | Padaviation is an airline providing private air charter and travel services. |
| HQ Country | |
| HQ City | Bühren |
| Deal Date | 28 Apr 2026 |
| Round | Strategic investment |
| Raised | undisclosed |
| Investors | TransMedics |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all TransMedics investments and their VC round multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout TransMedics
| When was TransMedics founded? | TransMedics was founded in 2018. |
| Where is TransMedics headquartered? | TransMedics is headquartered in United States. |
| How many employees does TransMedics have? | As of today, TransMedics has over 898 employees. |
| Who is the CEO of TransMedics? | TransMedics' CEO is Waleed H. Hassanein. |
| Is TransMedics publicly listed? | Yes, TransMedics is a public company listed on Nasdaq. |
| What is the stock symbol of TransMedics? | TransMedics trades under TMDX ticker. |
| When did TransMedics go public? | TransMedics went public in 2019. |
| Who are competitors of TransMedics? | TransMedics main competitors include Sinbon Electronics, Double Medical Technology, Insight Lifetech, Elekta, Tecan Group, GN Store Nord, Jeol, Jafron Biomedical, Axogen, LeMaitre Vascular. |
| What is the current market cap of TransMedics? | TransMedics' current market cap is $2B. |
| What is the current revenue of TransMedics? | TransMedics' last 12 months revenue is $659M. |
| What is the current revenue growth of TransMedics? | TransMedics revenue growth (NTM/LTM) is 20%. |
| What is the current EV/Revenue multiple of TransMedics? | Current revenue multiple of TransMedics is 4.2x. |
| What is the current EBITDA of TransMedics? | TransMedics' last 12 months EBITDA is $159M. |
| What is TransMedics' EBITDA margin? | TransMedics' last 12 months EBITDA margin is 24%. |
| What is the current EV/EBITDA multiple of TransMedics? | Current EBITDA multiple of TransMedics is 17.4x. |
| What is the current FCF of TransMedics? | TransMedics' last 12 months FCF is $90M. |
| What is TransMedics' FCF margin? | TransMedics' last 12 months FCF margin is 14%. |
| What is the current EV/FCF multiple of TransMedics? | Current FCF multiple of TransMedics is 30.8x. |
| How many companies TransMedics has acquired to date? | As of June 2026, TransMedics has acquired 1 company. |
| What was the largest acquisition by TransMedics? | $18M acquisition of Summit Aviation on 1st August 2023 was the largest M&A TransMedics has done to date. |
| What companies TransMedics acquired? | TransMedics acquired Summit Aviation. |
| In how many companies TransMedics has invested to date? | As of June 2026, TransMedics has invested in 1 company. |
| What was the last TransMedics investment? | On 28th April 2026 TransMedics invested in Padaviation, participating in a Strategic investment round. |
| In what companies TransMedics invested in? | TransMedics invested in Padaviation. |
See public comps similar to TransMedics
Lists including TransMedics
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

